US › Healthcare

Profound Medical Corp (PROF)

US · Healthcare · Medical Devices

$8.36+1.46%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$5.3M
Revenue YoY
+100.8%
Net profit
$-7.0M
Profit YoY
+35.1%
EPS
$-0.19
EPS estimate
$-0.25
Net margin
-132.2%

EPS came in at -0.19 against a street estimate of -0.25 — a beat of 24.0%.

Key statistics

Market cap
$268.2M
Forward P/E
0.0
P/B
4.50
Book value
$1.64
EPS (TTM)
$-1.24
52-week high
$8.95
52-week low
$3.76
50-day MA
$6.87
200-day MA
$6.76
Beta
0.53

Analyst view

Analysts rate Profound Medical Corp a strong buy (5 buy, 0 hold, 0 sell out of 5) with an average price target of $11.14.

Shareholding

Insiders
4.07%
Institutions
44.55%

Largest institutional holders

FundStake
Fidelity International Ltd6.44%
Gagnon Securities LLC5.35%
Royce & Associates, LP3.07%
Timelo Investment Management Inc.3.07%
Gagnon Advisors, LLC2.65%
Letko, Brosseau & Associates Inc.2.62%
Rosalind Advisors, Inc.2.28%
Z3 Capital Partners, LLC2.26%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Profound Medical Corp — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.